A continuing dialogue, prior to price-setting, will lead to a greater understanding of the underlying corporate pricing process and the needs of the community. Such an understanding is required for an overall strategy to fix drug prices at a level that encourages investment in developing new antiviral products while increasing access to present treatments. Exploring avenues for reasonable returns on investment while eliminating profiteering ought to be the united goal of both industry and community. Reproduced with permission. Inc. All rights reserved.
Noncommercial reproduction is encouraged.
Subscription lists are kept confidential. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only.